RxDoctor Payments Data

John Stein, PA

Physician Assistant · Morgantown, WVNPI 1265980452

Payments from drug & device makers

$3,267in general payments, 2019–2025

Across 205 payments — averaging $15.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Otsuka America Pharmaceutical, Inc.$344
  • Indivior Inc.$308
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$238
  • Vanda Pharmaceuticals Inc.$232
  • Axsome Therapeutics, Inc.$162
  • plus $926 from 12 others

What the payments were for

  • Food & beverage$3,20598%
  • Education$622%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,267 in reported general payments places this provider in the 90th percentile of 833 physician assistant providers in West Virginia.

See all physician assistant providers in West Virginia

Medicare billing

Part B allowed, 2024
$16,584
Medicare patients
24
Services billed
176

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole26$37,898
Lurasidone Hcl33$8,935
SuboxoneBuprenorphine Hcl/Naloxone Hcl38$8,693
TrintellixVortioxetine Hydrobromide14$6,732
BelsomraSuvorexant12$5,115
Paliperidone ErPaliperidone12$4,388
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl40$2,433
Duloxetine Hcl88$1,672
Desvenlafaxine Succinate ErDesvenlafaxine Succinate35$1,396
Oxcarbazepine37$1,311
Bupropion XlBupropion Hcl75$1,254
Buspirone Hcl82$1,178
Fluvoxamine Maleate14$785
Olanzapine42$704
Aripiprazole37$609

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$344$37,89826 claims
Indivior Inc.Suboxone$308$8,69338 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$142$6,73214 claims
Almatica Pharma LLCSertraline Hcl$29$18340 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 833 physician assistant providers in West Virginia.

Other physician assistant in Morgantown

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →